Cre recombinase, expressed under the control of the Sst promoter, was expected to trigger DTA expression in SST-producing cells, leading to cell-specific ablation (Figure S1B-C)
(Please note that there many vision loss lawsuits filed in New Jersey state court which may turn into a coordinated mass tort lawsuit.) September 9, 2025- The FDA issued a warning letter against Novo Nordisk concerning a promotional communications, direct-to-consumer video titled An Oprah Special: Shame, Blame, and the Weight Loss Revolution, regarding WEGOVY and OZEMPIC
doi: 10.1523/JNEUROSCI.0567-10.2010 76 SalehNMoutereauSDurrAKrystkowiakPAzulayJ-PTranchantCet al
Alongside their weight-loss effects by inhibiting appetite, GLP-1 receptor agonists also lead to reductions in lean body mass, including muscle and supportive fat pads, which can result in unintended effects: hollowing of the face, softening of the jawline, loss of core strength, or laxity in the neck and lower face
doi: 10.1007/978-1-0716-2473-9_6